The
company said the business, which brought in $8.6 billion in
sales in 2021, will focus on wound care, oral care and
healthcare technology.
It expects to complete the transaction by end of 2023.
The diversified manufacturer on Tuesday reported a fall in
second-quarter adjusted profit as COVID-19 lockdowns in China
impacted the company's manufacturing operations in the country.
3M's adjusted profit fell to $2.48 per share from $2.75 per
share a year earlier.
(Reporting by Kannaki Deka in Bengaluru; Editing by Shinjini
Ganguli)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|